Journal of Surgical Research
Volume 146, Issue 1 , Pages 3-10 , 1 May 2008

Novel Methods for Delivery of Cell-Based Therapies

  • M. Cecilia Crisanti, M.D.

      Affiliations

    • Department of Pediatric Surgery, St. Christopher’s Hospital for Children, Drexel University College of Medicine, Philadelphia, Pennsylvania
    • Department of Thoracic Oncology, University of Pennsylvania, Philadelphia, Pennsylvania
    • Corresponding Author InformationTo whom correspondence and reprint requests should be addressed at Abramson Research Center, University of Pennsylvania, School of Medicine, 3615 Civic Center Blvd., Suite 1015F, Philadelphia, PA 19104.
    • ,
  • Sirma H. Koutzaki, M.S.

      Affiliations

    • Department of Pediatric Surgery, St. Christopher’s Hospital for Children, Drexel University College of Medicine, Philadelphia, Pennsylvania
    • ,
  • Mark J. Mondrinos, B.S.

      Affiliations

    • School of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, Pennsylvania
    • ,
  • Peter I. Lelkes, Ph.D.

      Affiliations

    • School of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, Pennsylvania
    • ,
  • Christine M. Finck, M.D.

      Affiliations

    • Department of Pediatric Surgery, St. Christopher’s Hospital for Children, Drexel University College of Medicine, Philadelphia, Pennsylvania
    • Department of Pediatric Surgery, Connecticut Children’s Hospital, Hartford, Connecticut

Received 8 January 2007

References 

  1. Compernolle V, Brusselmans K, Acker T, et al. Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fetal respiratory distress in premature mice. Nat Med. 2002;8:702
  2. Leinwand MJ, Tefft JD, Zhao J, et al. Nitrofen inhibition of pulmonary growth and development occurs in early embryonic mouse. J Pediatr Surg. 2002;37:1263
  3. Pollok JM, Vacanti JP. Tissue engineering. Semin Pediatr Surg. 1996;5:191
  4. Kim SS, Vacanti JP. The current status of tissue engineering as potential therapy. Semin Pediatr Surg. 1999;8:119
  5. Nerem RM. Tissue engineering: Confronting the transplantation crisis. Proc Inst Mech Eng [H]. 2000;214:95
  6. Stock UA, Vacanti JP. Tissue engineering: Current state and prospects. Annu Rev Med. 2001;52:443
  7. Fuchs JR, Nasseri BA, Vacanti JP. Tissue engineering: A 21st century solution to surgical reconstruction. Ann Thorac Surg. 2001;72:577
  8. Nerem RM. Cellular engineering. Ann Biomed Eng. 1991;19:529
  9. Mondrinos MJ, Koutzaki S, Jiwanmall E, et al. Engineering three-dimensional pulmonary tissue constructs. Tissue Eng. 2006;12:717
  10. Mondrinos MJ, Koutzaki S, Finck CM, et al. A tissue engineered model of developing distal lung tissue. AJP Lung. 2006;unpublished, under revision
  11. Bates SR, Gonzales LW, Tao JQ, et al. Recovery of rat Type II cell surfactant components during primary cell culture. Am J Physiol Lung Cell Mol Physiol. 2002;282:L267
  12. Yuli I, Lelkes PI. Neutral endopeptidase activity in the interaction of N-formyl-L-methionyl-L-leucyl-L-phenylalanine with human polymorphonuclear leukocytes. Eur J Biochem. 1991;201:421
  13. Baber SR, Deng W, Master RG, et al. Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2007;292:H1120
  14. Yang SC, Batra RK, Hillinger S, et al. Intrapulmonary administration of CCL21 gene-modified dendritic cells reduces burden in spontaneous murine bronchoalveolar cell carcinoma. Cancer Res. 2006;66:3205
  15. Andrade CF, Wong AP, Waddell TK, et al. Cell-based tissue engineering for lung regeneration. Am J Physiol Lung Cell Mol Physiol. 2007;292:L510

PII: S0022-4804(07)00425-8

doi: 10.1016/j.jss.2007.06.010

Journal of Surgical Research
Volume 146, Issue 1 , Pages 3-10 , 1 May 2008

Article Tools

* Image Usage & Resolution